Click for best price
Veterinary Autogenous Vaccines Market Size, Share 2023
The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms.
This report aims to provide a comprehensive presentation of the global market for Veterinary Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Autogenous Vaccines. This report contains market size and forecasts of Veterinary Autogenous Vaccines in global, including the following market information:
Global Veterinary Autogenous Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Autogenous Vaccines Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Veterinary Autogenous Vaccines companies in 2022 (%)
The global Veterinary Autogenous Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pet Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Autogenous Vaccines include ZOETIS, Ceva Biovac, Boehringer Ingelheim, Gallant Custom Laboratories, UVAXX, Bimeda, Dyntec, Elanco Animal Health and Vaxxinova, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Autogenous Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Autogenous Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Veterinary Autogenous Vaccines Market Segment Percentages, by Type, 2022 (%)
Pet Vaccine
Livestock Vaccine
Global Veterinary Autogenous Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Veterinary Autogenous Vaccines Market Segment Percentages, by Application, 2022 (%)
Research Facility
Pet Clinic
Ranches
Others
Global Veterinary Autogenous Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Veterinary Autogenous Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Autogenous Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Veterinary Autogenous Vaccines revenues share in global market, 2022 (%)
Key companies Veterinary Autogenous Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Veterinary Autogenous Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ZOETIS
Ceva Biovac
Boehringer Ingelheim
Gallant Custom Laboratories
UVAXX
Bimeda
Dyntec
Elanco Animal Health
Vaxxinova
Hygieia Biological Laboratories
Deltamune Animal Health
Genova Labs
Newport Laboratories
Epitopix
LOHMANN TIERZUCHT
Addison Biological Laboratory
Phibro Animal Health Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Autogenous Vaccines, market overview.
Chapter 2: Global Veterinary Autogenous Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Autogenous Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Veterinary Autogenous Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Veterinary Autogenous Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Autogenous Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Autogenous Vaccines Overall Market Size
2.1 Global Veterinary Autogenous Vaccines Market Size: 2022 VS 2029
2.2 Global Veterinary Autogenous Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Veterinary Autogenous Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Veterinary Autogenous Vaccines Players in Global Market
3.2 Top Global Veterinary Autogenous Vaccines Companies Ranked by Revenue
3.3 Global Veterinary Autogenous Vaccines Revenue by Companies
3.4 Global Veterinary Autogenous Vaccines Sales by Companies
3.5 Global Veterinary Autogenous Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Veterinary Autogenous Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Veterinary Autogenous Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Autogenous Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Autogenous Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Autogenous Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Veterinary Autogenous Vaccines Market Size Markets, 2022 & 2029
4.1.2 Pet Vaccine
4.1.3 Livestock Vaccine
4.2 By Type - Global Veterinary Autogenous Vaccines Revenue & Forecasts
4.2.1 By Type - Global Veterinary Autogenous Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Veterinary Autogenous Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Veterinary Autogenous Vaccines Sales & Forecasts
4.3.1 By Type - Global Veterinary Autogenous Vaccines Sales, 2018-2023
4.3.2 By Type - Global Veterinary Autogenous Vaccines Sales, 2024-2029
4.3.3 By Type - Global Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Veterinary Autogenous Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Veterinary Autogenous Vaccines Market Size, 2022 & 2029
5.1.2 Research Facility
5.1.3 Pet Clinic
5.1.4 Ranches
5.1.5 Others
5.2 By Application - Global Veterinary Autogenous Vaccines Revenue & Forecasts
5.2.1 By Application - Global Veterinary Autogenous Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Veterinary Autogenous Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Veterinary Autogenous Vaccines Sales & Forecasts
5.3.1 By Application - Global Veterinary Autogenous Vaccines Sales, 2018-2023
5.3.2 By Application - Global Veterinary Autogenous Vaccines Sales, 2024-2029
5.3.3 By Application - Global Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Veterinary Autogenous Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Veterinary Autogenous Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Veterinary Autogenous Vaccines Revenue & Forecasts
6.2.1 By Region - Global Veterinary Autogenous Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Veterinary Autogenous Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Veterinary Autogenous Vaccines Sales & Forecasts
6.3.1 By Region - Global Veterinary Autogenous Vaccines Sales, 2018-2023
6.3.2 By Region - Global Veterinary Autogenous Vaccines Sales, 2024-2029
6.3.3 By Region - Global Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Veterinary Autogenous Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Veterinary Autogenous Vaccines Sales, 2018-2029
6.4.3 US Veterinary Autogenous Vaccines Market Size, 2018-2029
6.4.4 Canada Veterinary Autogenous Vaccines Market Size, 2018-2029
6.4.5 Mexico Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Veterinary Autogenous Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Veterinary Autogenous Vaccines Sales, 2018-2029
6.5.3 Germany Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5.4 France Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5.5 U.K. Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5.6 Italy Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5.7 Russia Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Veterinary Autogenous Vaccines Market Size, 2018-2029
6.5.9 Benelux Veterinary Autogenous Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Veterinary Autogenous Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Veterinary Autogenous Vaccines Sales, 2018-2029
6.6.3 China Veterinary Autogenous Vaccines Market Size, 2018-2029
6.6.4 Japan Veterinary Autogenous Vaccines Market Size, 2018-2029
6.6.5 South Korea Veterinary Autogenous Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Veterinary Autogenous Vaccines Market Size, 2018-2029
6.6.7 India Veterinary Autogenous Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Veterinary Autogenous Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Veterinary Autogenous Vaccines Sales, 2018-2029
6.7.3 Brazil Veterinary Autogenous Vaccines Market Size, 2018-2029
6.7.4 Argentina Veterinary Autogenous Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Veterinary Autogenous Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Veterinary Autogenous Vaccines Sales, 2018-2029
6.8.3 Turkey Veterinary Autogenous Vaccines Market Size, 2018-2029
6.8.4 Israel Veterinary Autogenous Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Veterinary Autogenous Vaccines Market Size, 2018-2029
6.8.6 UAE Veterinary Autogenous Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ZOETIS
7.1.1 ZOETIS Company Summary
7.1.2 ZOETIS Business Overview
7.1.3 ZOETIS Veterinary Autogenous Vaccines Major Product Offerings
7.1.4 ZOETIS Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 ZOETIS Key News & Latest Developments
7.2 Ceva Biovac
7.2.1 Ceva Biovac Company Summary
7.2.2 Ceva Biovac Business Overview
7.2.3 Ceva Biovac Veterinary Autogenous Vaccines Major Product Offerings
7.2.4 Ceva Biovac Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Ceva Biovac Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Autogenous Vaccines Major Product Offerings
7.3.4 Boehringer Ingelheim Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Gallant Custom Laboratories
7.4.1 Gallant Custom Laboratories Company Summary
7.4.2 Gallant Custom Laboratories Business Overview
7.4.3 Gallant Custom Laboratories Veterinary Autogenous Vaccines Major Product Offerings
7.4.4 Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Gallant Custom Laboratories Key News & Latest Developments
7.5 UVAXX
7.5.1 UVAXX Company Summary
7.5.2 UVAXX Business Overview
7.5.3 UVAXX Veterinary Autogenous Vaccines Major Product Offerings
7.5.4 UVAXX Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 UVAXX Key News & Latest Developments
7.6 Bimeda
7.6.1 Bimeda Company Summary
7.6.2 Bimeda Business Overview
7.6.3 Bimeda Veterinary Autogenous Vaccines Major Product Offerings
7.6.4 Bimeda Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Bimeda Key News & Latest Developments
7.7 Dyntec
7.7.1 Dyntec Company Summary
7.7.2 Dyntec Business Overview
7.7.3 Dyntec Veterinary Autogenous Vaccines Major Product Offerings
7.7.4 Dyntec Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Dyntec Key News & Latest Developments
7.8 Elanco Animal Health
7.8.1 Elanco Animal Health Company Summary
7.8.2 Elanco Animal Health Business Overview
7.8.3 Elanco Animal Health Veterinary Autogenous Vaccines Major Product Offerings
7.8.4 Elanco Animal Health Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Elanco Animal Health Key News & Latest Developments
7.9 Vaxxinova
7.9.1 Vaxxinova Company Summary
7.9.2 Vaxxinova Business Overview
7.9.3 Vaxxinova Veterinary Autogenous Vaccines Major Product Offerings
7.9.4 Vaxxinova Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Vaxxinova Key News & Latest Developments
7.10 Hygieia Biological Laboratories
7.10.1 Hygieia Biological Laboratories Company Summary
7.10.2 Hygieia Biological Laboratories Business Overview
7.10.3 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Major Product Offerings
7.10.4 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Hygieia Biological Laboratories Key News & Latest Developments
7.11 Deltamune Animal Health
7.11.1 Deltamune Animal Health Company Summary
7.11.2 Deltamune Animal Health Veterinary Autogenous Vaccines Business Overview
7.11.3 Deltamune Animal Health Veterinary Autogenous Vaccines Major Product Offerings
7.11.4 Deltamune Animal Health Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Deltamune Animal Health Key News & Latest Developments
7.12 Genova Labs
7.12.1 Genova Labs Company Summary
7.12.2 Genova Labs Veterinary Autogenous Vaccines Business Overview
7.12.3 Genova Labs Veterinary Autogenous Vaccines Major Product Offerings
7.12.4 Genova Labs Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Genova Labs Key News & Latest Developments
7.13 Newport Laboratories
7.13.1 Newport Laboratories Company Summary
7.13.2 Newport Laboratories Veterinary Autogenous Vaccines Business Overview
7.13.3 Newport Laboratories Veterinary Autogenous Vaccines Major Product Offerings
7.13.4 Newport Laboratories Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Newport Laboratories Key News & Latest Developments
7.14 Epitopix
7.14.1 Epitopix Company Summary
7.14.2 Epitopix Business Overview
7.14.3 Epitopix Veterinary Autogenous Vaccines Major Product Offerings
7.14.4 Epitopix Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Epitopix Key News & Latest Developments
7.15 LOHMANN TIERZUCHT
7.15.1 LOHMANN TIERZUCHT Company Summary
7.15.2 LOHMANN TIERZUCHT Business Overview
7.15.3 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Major Product Offerings
7.15.4 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 LOHMANN TIERZUCHT Key News & Latest Developments
7.16 Addison Biological Laboratory
7.16.1 Addison Biological Laboratory Company Summary
7.16.2 Addison Biological Laboratory Business Overview
7.16.3 Addison Biological Laboratory Veterinary Autogenous Vaccines Major Product Offerings
7.16.4 Addison Biological Laboratory Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Addison Biological Laboratory Key News & Latest Developments
7.17 Phibro Animal Health Corporation
7.17.1 Phibro Animal Health Corporation Company Summary
7.17.2 Phibro Animal Health Corporation Business Overview
7.17.3 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Major Product Offerings
7.17.4 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 Phibro Animal Health Corporation Key News & Latest Developments
8 Global Veterinary Autogenous Vaccines Production Capacity, Analysis
8.1 Global Veterinary Autogenous Vaccines Production Capacity, 2018-2029
8.2 Veterinary Autogenous Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Veterinary Autogenous Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Veterinary Autogenous Vaccines Supply Chain Analysis
10.1 Veterinary Autogenous Vaccines Industry Value Chain
10.2 Veterinary Autogenous Vaccines Upstream Market
10.3 Veterinary Autogenous Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Veterinary Autogenous Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Veterinary Autogenous Vaccines in Global Market
Table 2. Top Veterinary Autogenous Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Veterinary Autogenous Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Veterinary Autogenous Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Veterinary Autogenous Vaccines Sales by Companies, (K Doses), 2018-2023
Table 6. Global Veterinary Autogenous Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Veterinary Autogenous Vaccines Price (2018-2023) & (US$/Dose)
Table 8. Global Manufacturers Veterinary Autogenous Vaccines Product Type
Table 9. List of Global Tier 1 Veterinary Autogenous Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Autogenous Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Veterinary Autogenous Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Veterinary Autogenous Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Veterinary Autogenous Vaccines Sales (K Doses), 2018-2023
Table 15. By Type - Global Veterinary Autogenous Vaccines Sales (K Doses), 2024-2029
Table 16. By Application ? Global Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Veterinary Autogenous Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Veterinary Autogenous Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Veterinary Autogenous Vaccines Sales (K Doses), 2018-2023
Table 20. By Application - Global Veterinary Autogenous Vaccines Sales (K Doses), 2024-2029
Table 21. By Region ? Global Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Veterinary Autogenous Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Veterinary Autogenous Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Veterinary Autogenous Vaccines Sales (K Doses), 2018-2023
Table 25. By Region - Global Veterinary Autogenous Vaccines Sales (K Doses), 2024-2029
Table 26. By Country - North America Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Veterinary Autogenous Vaccines Sales, (K Doses), 2018-2023
Table 29. By Country - North America Veterinary Autogenous Vaccines Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Veterinary Autogenous Vaccines Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Veterinary Autogenous Vaccines Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Veterinary Autogenous Vaccines Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Veterinary Autogenous Vaccines Sales, (K Doses), 2024-2029
Table 38. By Country - South America Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Veterinary Autogenous Vaccines Sales, (K Doses), 2018-2023
Table 41. By Country - South America Veterinary Autogenous Vaccines Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Veterinary Autogenous Vaccines Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Veterinary Autogenous Vaccines Sales, (K Doses), 2024-2029
Table 46. ZOETIS Company Summary
Table 47. ZOETIS Veterinary Autogenous Vaccines Product Offerings
Table 48. ZOETIS Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 49. ZOETIS Key News & Latest Developments
Table 50. Ceva Biovac Company Summary
Table 51. Ceva Biovac Veterinary Autogenous Vaccines Product Offerings
Table 52. Ceva Biovac Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 53. Ceva Biovac Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Veterinary Autogenous Vaccines Product Offerings
Table 56. Boehringer Ingelheim Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Gallant Custom Laboratories Company Summary
Table 59. Gallant Custom Laboratories Veterinary Autogenous Vaccines Product Offerings
Table 60. Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 61. Gallant Custom Laboratories Key News & Latest Developments
Table 62. UVAXX Company Summary
Table 63. UVAXX Veterinary Autogenous Vaccines Product Offerings
Table 64. UVAXX Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 65. UVAXX Key News & Latest Developments
Table 66. Bimeda Company Summary
Table 67. Bimeda Veterinary Autogenous Vaccines Product Offerings
Table 68. Bimeda Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 69. Bimeda Key News & Latest Developments
Table 70. Dyntec Company Summary
Table 71. Dyntec Veterinary Autogenous Vaccines Product Offerings
Table 72. Dyntec Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 73. Dyntec Key News & Latest Developments
Table 74. Elanco Animal Health Company Summary
Table 75. Elanco Animal Health Veterinary Autogenous Vaccines Product Offerings
Table 76. Elanco Animal Health Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 77. Elanco Animal Health Key News & Latest Developments
Table 78. Vaxxinova Company Summary
Table 79. Vaxxinova Veterinary Autogenous Vaccines Product Offerings
Table 80. Vaxxinova Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 81. Vaxxinova Key News & Latest Developments
Table 82. Hygieia Biological Laboratories Company Summary
Table 83. Hygieia Biological Laboratories Veterinary Autogenous Vaccines Product Offerings
Table 84. Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 85. Hygieia Biological Laboratories Key News & Latest Developments
Table 86. Deltamune Animal Health Company Summary
Table 87. Deltamune Animal Health Veterinary Autogenous Vaccines Product Offerings
Table 88. Deltamune Animal Health Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 89. Deltamune Animal Health Key News & Latest Developments
Table 90. Genova Labs Company Summary
Table 91. Genova Labs Veterinary Autogenous Vaccines Product Offerings
Table 92. Genova Labs Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 93. Genova Labs Key News & Latest Developments
Table 94. Newport Laboratories Company Summary
Table 95. Newport Laboratories Veterinary Autogenous Vaccines Product Offerings
Table 96. Newport Laboratories Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 97. Newport Laboratories Key News & Latest Developments
Table 98. Epitopix Company Summary
Table 99. Epitopix Veterinary Autogenous Vaccines Product Offerings
Table 100. Epitopix Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 101. Epitopix Key News & Latest Developments
Table 102. LOHMANN TIERZUCHT Company Summary
Table 103. LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Product Offerings
Table 104. LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 105. LOHMANN TIERZUCHT Key News & Latest Developments
Table 106. Addison Biological Laboratory Company Summary
Table 107. Addison Biological Laboratory Veterinary Autogenous Vaccines Product Offerings
Table 108. Addison Biological Laboratory Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 109. Addison Biological Laboratory Key News & Latest Developments
Table 110. Phibro Animal Health Corporation Company Summary
Table 111. Phibro Animal Health Corporation Veterinary Autogenous Vaccines Product Offerings
Table 112. Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 113. Phibro Animal Health Corporation Key News & Latest Developments
Table 114. Veterinary Autogenous Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 115. Global Veterinary Autogenous Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Veterinary Autogenous Vaccines Production by Region, 2018-2023 (K Doses)
Table 117. Global Veterinary Autogenous Vaccines Production by Region, 2024-2029 (K Doses)
Table 118. Veterinary Autogenous Vaccines Market Opportunities & Trends in Global Market
Table 119. Veterinary Autogenous Vaccines Market Drivers in Global Market
Table 120. Veterinary Autogenous Vaccines Market Restraints in Global Market
Table 121. Veterinary Autogenous Vaccines Raw Materials
Table 122. Veterinary Autogenous Vaccines Raw Materials Suppliers in Global Market
Table 123. Typical Veterinary Autogenous Vaccines Downstream
Table 124. Veterinary Autogenous Vaccines Downstream Clients in Global Market
Table 125. Veterinary Autogenous Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Veterinary Autogenous Vaccines Segment by Type in 2022
Figure 2. Veterinary Autogenous Vaccines Segment by Application in 2022
Figure 3. Global Veterinary Autogenous Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Veterinary Autogenous Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Veterinary Autogenous Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Veterinary Autogenous Vaccines Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Veterinary Autogenous Vaccines Revenue in 2022
Figure 9. By Type - Global Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Veterinary Autogenous Vaccines Price (US$/Dose), 2018-2029
Figure 13. By Application - Global Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Veterinary Autogenous Vaccines Price (US$/Dose), 2018-2029
Figure 17. By Region - Global Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 23. US Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 37. China Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Veterinary Autogenous Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Veterinary Autogenous Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Veterinary Autogenous Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Veterinary Autogenous Vaccines Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Veterinary Autogenous Vaccines by Region, 2022 VS 2029
Figure 54. Veterinary Autogenous Vaccines Industry Value Chain
Figure 55. Marketing Channels
